2 completed, 2 terminated, 1 unknown. 3 Phase 1, 2 Early Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow CDA Research Group, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 3VM for Treatment of Chronic Osteoarthritis Knee Pain Experimental: 3VM1001 active 2g Cream 3 times daily, Experimental: 3VM1001 active 3g Cream 3 times daily, Experimental: 3VM1001 active 3g Cream 4 times daily - Arthritis, Degenerative | Phase 1 / Phase 2 | Completed | CDA Research Group, Inc. | 150 | 2017-04-30 | 2018-07-06 |
| 3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN) 3VM1001, Placebo - Treatment of PHN | Early Phase 1 | Completed | CDA Research Group, Inc. | 28 | 2017-03-06 | 2018-07-10 |
| Assessment of the Safety and Efficacy of 3VM1001 Cream for Treatment of Chronic Pain Caused by Knee Osteoarthritis. 3VM1001, Placebo for 3VM1001 - Osteoarthritis of Knee | Phase 1 | Unknown | CDA Research Group, Inc. | 50 | 2015-02-01 | 2015-08-21 |
| LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study LUXSOL copper containing cream, Metronidazole gel - Bacterial Vaginosis (BV) | Early Phase 1 | Terminated | CDA Research Group, Inc. | 50 | 2014-06-01 | 2018-04-05 |
| GoldenCareTM for the Treatment of Bacterial Vaginosis GoldenCare, Metronidazole - Bacterial Vaginosis | Phase 1 / Phase 2 | Terminated | CDA Research Group, Inc. | 8 | 2013-02-01 | 2015-02-03 |
Vaginosis, Bacterial (2) · Herpes Zoster (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Pain (1)
Metronidazole (2)
United States (4)